Get started
Author

Mingrui Zou

Observed name: M. Zou
ORCID: 0009-0009-4064-6619
Observed ORCID: 0009-0009-4064-6619
OpenAlex ID: A5019772300
Therapeutic Potential of Exosomes in Tendon and Tendon–Bone Healing: A Systematic Review of Preclinical Studies
2023 · Mingrui Zou, Jingzhou Wang, et al. · Journal of Functional Biomaterials · 41
PDF
Proteome-Wide Mendelian Randomization and Colocalization Analysis Identify Therapeutic Targets for Knee and Hip Osteoarthritis
2024 · Mingrui Zou, Zhenxing Shao · Biomolecules · 22
PDF
Construction and evaluation of sarcopenia risk prediction model for patients with diabetes: a study based on the China health and retirement longitudinal study (CHARLS)
2024 · Mingrui Zou, Zhenxing Shao · Diabetology & Metabolic Syndrome · 13
PDF
Cross-Tissue Regulatory Network Analyses Reveal Novel Susceptibility Genes and Potential Mechanisms for Endometriosis
2024 · Mingrui Zou, Mingmei Lin, et al. · Biology · 5
PDF
Novel Protein Biomarkers and Therapeutic Targets for Type 1 Diabetes and Its Complications: Insights from Summary-Data-Based Mendelian Randomization and Colocalization Analysis
2024 · Mingrui Zou, Jichun Yang · Pharmaceuticals · 5
Dietary patterns, polygenic risk, and kidney cancer incidence: a UK Biobank cohort study
2025 · Mingrui Zou, Ruiyi Deng, et al. · Journal of Translational Medicine · 4
PDF
Identify novel therapeutic targets for type II diabetes and periodontitis: insights from single-cell analysis and Mendelian randomization analysis
2024 · Mingrui Zou, Jichun Yang · Frontiers in Endocrinology · 3
Two-Sample Network Mendelian Randomization and Single-Cell Analysis Reveal the Causal Associations and Underlying Mechanisms Between Antihypertensive Drugs and Kidney Cancer
2025 · Ruiyi Deng, Mingrui Zou, et al. · Journal of Cancer · 2
PDF
Extracellular vesicles-mediated metabolic reprogramming in prostate cancer progression and tumor microenvironment remodeling
2026 · Mingrui Zou, Ruiyi Deng, et al. · Cellular & Molecular Biology Letters
Beyond hypoxia and ccRCC: the expanding universe of VHL novel targets and next-generation therapeutics
2026 · Ruiyi Deng, Boyuan Wang, et al. · Biomarker Research
PDF
Risk-based screening and prognostic analysis for second primary malignancies in kidney cancer patients: a retrospective cohort study based on large-scale population and Mendelian randomization analysis
2025 · Mingrui Zou, Ruiyi Deng, et al. · International Journal of Medical Sciences
PDF
Ip16-03 Single-cell Endoplasmic Reticulum Stress Patterns Guide Intercellular Communication of Tumor Microenvironment That Influence the Progression and Prognosis of Clear Cell Renal Cell Carcinoma
2025 · Mingrui Zou, Zedan Zhang, et al. · The Journal of Urology
Mp38-07 Risk-based Screen and Prognostic Analysis for Second Primary Malignancies in Renal Cell Carcinoma Patients: a Retrospective Cohort Study Based on Large-scale Population and Mendelian Randomization Analysis
2025 · Mingrui Zou, Ruiyi Deng, et al. · The Journal of Urology
P327 – Risk-based screen and prognostic analysis for second primary malignancies in patients with renal cell carcinoma: A retrospective cohort study based on large-scale population and mendelian randomization analysis
2025 · M. Zou, R. Deng, et al. · European Urology
Works count: 14
Citation count: 95
H-index: 5
I10-index: 3
Year
Topic
Type